Drugs / Individual peptide vaccination
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03559413 | Jun 2016 → Mar 2022 | childhood acute lymphoblastic leukemia | University Children's Hospital Tuebingen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Individual peptide vaccination | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03559413 ↗ |
| Modality | Vaccine | “individualized peptide vaccination approach” NCT03559413 ↗ |
| Route | Other | “Intradermal injection of a cocktail of 3-5 individual HLA-binding peptides.” NCT03559413 ↗ |